Literature DB >> 8898364

Induction of p18INK4c and its predominant association with CDK4 and CDK6 during myogenic differentiation.

D S Franklin1, Y Xiong.   

Abstract

Terminal cell differentiation involves permanent withdrawal from the cell division cycle. The inhibitors of cyclin-dependent kinases (CDKs) are potential molecules functioning to couple cell cycle arrest and cell differentiation. In murine C2C12 myoblast cells, G1 CDK enzymes (CDK2, CDK4, and CDK6) associate with four CDK inhibitors: p18INK4c, p19INK4d, p21, and p27Kip1. During induced myogenesis, p21 and its associated CDK proteins underwent an initial increase followed by a decrease as cells became terminally differentiated. The level of p27 protein gradually increased, but the amount of total associated CDK proteins remained unchanged. p19 protein decreased gradually during differentiation, as did its associated CDK4 protein. In contrast, p18 protein increased 50-fold, from negligible levels in proliferating myoblasts to clearly detectable levels within 8-12 h of myogenic induction. This initial rise was followed by a precipitous increase between 12 and 24 h postinduction, with p18 protein finally accumulating to its highest level in terminally differentiated cells. Induction of p18 correlated with increased and sequential complex formation--first increasing association with CDK6 and then with CDK4 over the course of myogenic differentiation. All of the CDK6 and half of the CDK4 were complexed with p18 in terminally differentiated C2C12 cells as well as in adult mouse muscle tissue. Finally, kinase activity of CDK2 and CDK4 decreases as C2C12 cells differentiate, whereas the CDK6 kinase activity is low in both proliferating myoblasts and differentiated myotubes. Our results indicate that p18 may play a critical role in causing and/or maintaining permanent cell cycle arrest associated with mature muscle formation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8898364      PMCID: PMC276008          DOI: 10.1091/mbc.7.10.1587

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  60 in total

1.  Ability of adenovirus 5 E1A proteins to suppress differentiation of BC3H1 myoblasts correlates with their binding to a 300 kDa cellular protein.

Authors:  J S Mymryk; R W Lee; S T Bayley
Journal:  Mol Biol Cell       Date:  1992-10       Impact factor: 4.138

2.  Inhibition of muscle differentiation by the adenovirus E1a protein: repression of the transcriptional activating function of the HLH protein Myf-5.

Authors:  T Braun; E Bober; H H Arnold
Journal:  Genes Dev       Date:  1992-05       Impact factor: 11.361

3.  Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle.

Authors:  D Yaffe; O Saxel
Journal:  Nature       Date:  1977 Dec 22-29       Impact factor: 49.962

4.  Myogenin, a factor regulating myogenesis, has a domain homologous to MyoD.

Authors:  W E Wright; D A Sassoon; V K Lin
Journal:  Cell       Date:  1989-02-24       Impact factor: 41.582

5.  D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA.

Authors:  Y Xiong; H Zhang; D Beach
Journal:  Cell       Date:  1992-10-30       Impact factor: 41.582

6.  SV40 large T inhibits myogenic differentiation partially through inducing c-jun.

Authors:  T Endo
Journal:  J Biochem       Date:  1992-09       Impact factor: 3.387

7.  Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins.

Authors:  H Matsushime; M E Ewen; D K Strom; J Y Kato; S K Hanks; M F Roussel; C J Sherr
Journal:  Cell       Date:  1992-10-16       Impact factor: 41.582

8.  Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution.

Authors:  M H Lee; I Reynisdóttir; J Massagué
Journal:  Genes Dev       Date:  1995-03-15       Impact factor: 11.361

9.  A family of human cdc2-related protein kinases.

Authors:  M Meyerson; G H Enders; C L Wu; L K Su; C Gorka; C Nelson; E Harlow; L H Tsai
Journal:  EMBO J       Date:  1992-08       Impact factor: 11.598

10.  Growth factor control of skeletal muscle differentiation: commitment to terminal differentiation occurs in G1 phase and is repressed by fibroblast growth factor.

Authors:  C H Clegg; T A Linkhart; B B Olwin; S D Hauschka
Journal:  J Cell Biol       Date:  1987-08       Impact factor: 10.539

View more
  25 in total

1.  Cyclin dependent kinase inhibitors differentially modulate synergistic cytokine responsiveness of hematopoietic progenitor cells.

Authors:  Hal E Broxmeyer; David S Franklin; Scott Cooper; Giao Hangoc; Charlie Mantel
Journal:  Stem Cells Dev       Date:  2011-11-02       Impact factor: 3.272

2.  Cyclin D-cdk4 activity modulates the subnuclear localization and interaction of MEF2 with SRC-family coactivators during skeletal muscle differentiation.

Authors:  Jean-Bernard Lazaro; Peter J Bailey; Andrew B Lassar
Journal:  Genes Dev       Date:  2002-07-15       Impact factor: 11.361

3.  Transcriptional profile of GTP-mediated differentiation of C2C12 skeletal muscle cells.

Authors:  Rosa Mancinelli; Tiziana Pietrangelo; Geoffrey Burnstock; Giorgio Fanò; Stefania Fulle
Journal:  Purinergic Signal       Date:  2011-12-01       Impact factor: 3.765

4.  p19Ink4d is a tumor suppressor and controls pituitary anterior lobe cell proliferation.

Authors:  Feng Bai; Ho Lam Chan; Matthew D Smith; Hiroaki Kiyokawa; Xin-Hai Pei
Journal:  Mol Cell Biol       Date:  2014-03-31       Impact factor: 4.272

5.  CDK inhibitors for muscle stem cell differentiation and self-renewal.

Authors:  Amrudha Mohan; Atsushi Asakura
Journal:  J Phys Fit Sports Med       Date:  2017

6.  Role of metalloprotease disintegrin ADAM12 in determination of quiescent reserve cells during myogenic differentiation in vitro.

Authors:  Yi Cao; Zhefeng Zhao; Joanna Gruszczynska-Biegala; Anna Zolkiewska
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

7.  Cooperation of p27(Kip1) and p18(INK4c) in progestin-mediated cell cycle arrest in T-47D breast cancer cells.

Authors:  A Swarbrick; C S Lee; R L Sutherland; E A Musgrove
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

8.  Contrasting behavior of the p18INK4c and p16INK4a tumor suppressors in both replicative and oncogene-induced senescence.

Authors:  Sladjana Gagrica; Sharon Brookes; Emma Anderton; Janice Rowe; Gordon Peters
Journal:  Cancer Res       Date:  2011-11-11       Impact factor: 12.701

9.  Arsenic inhibits myogenic differentiation and muscle regeneration.

Authors:  Yuan-Peng Yen; Keh-Sung Tsai; Ya-Wen Chen; Chun-Fa Huang; Rong-Sen Yang; Shing-Hwa Liu
Journal:  Environ Health Perspect       Date:  2010-03-18       Impact factor: 9.031

10.  Haploinsufficiency of p18(INK4c) sensitizes mice to carcinogen-induced tumorigenesis.

Authors:  Feng Bai; Xin-Hai Pei; Virginia L Godfrey; Yue Xiong
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.